In today’s Pharmaceutical Executive Daily, we report on new data showing Wegovy’s potential to reduce liver injury in patients with MASH, Eli Lilly’s latest strategic collaborations in gene therapy, ...

The company's shares (LLY) climbed 2.3% Tuesday to end at $988.62 a share, after closing at a record high of $966.64 on Monday. The rally has pushed Lilly's market capitalization up to $934.6 billion, ...

Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

Mounjaro is priced at Rs 3,500 per 2.5 mg single-dose vial and Rs 4,375 per 5 mg single-dose vial, adding up to anywhere ...

What Happened: According to Reuters, Pfizer Inc (NYSE: PFE) won the bidding war against Novo Nordisk and will purchase ...

Novo Nordisk has cut prices of its weight-loss drug Wegovy by up to 37% in India. This move intensifies competition with Eli ...

By Rishika Sadam BENGALURU (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it had cut the price of its weight-loss ...

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...

Danish drugmaker Novo Nordisk on Tuesday announced slashing prices of its weight-loss drug Wegovy by up to 37 per cent in a ...